NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that it has filed a Premarket Approval Supplement (PMA-S) ...

Tonic-Clonic Seizures Treatment Market Trends There is a growing trend towards the use of combination therapies to manage tonic-clonic seizures. Combining multiple anti-seizure medications or ...

This page lists all known medications that could potentially lead to 'Tonic-clonic seizures' as a side effect. It's important to note that mild side effects are quite common with medications. The ...

Eisai announced results from a Phase 3 Study 332 trial of perampanel, an AMPA receptor antagonist in patients with primary generalized tonic-clonic (PGTC) seizures. Study 332 was a double-blind, ...

Individuals with focal onset epilepsy treated with azetukalner experienced sustained monthly seizure reduction and evidence of seizure freedom up to 48 months, according to data presented at the ...

Epilepsy is when the brain has an electrical misfire that causes multiple seizures. And depending on where the misfire takes place, the seizure will have different effects, such as freezing you or ...

CLEVELAND — November marks National Epilepsy Awareness Month, drawing attention to a neurological condition that affects almost 3 million adults and nearly half a million children across the United ...

November is Epilepsy Awareness Month. Many people may already be aware of the condition from its prevalence in medical dramas, but that portrayal is often exaggerated and does not fully encapsulate ...

The World Health Organization estimates that more than 50 million people worldwide have some form of epilepsy, a neurological disorder that is characterized by recurring episodes of seizure. While ...